These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 39415615)

  • 1. Quantitative Susceptibility Mapping Values Quantification in Deep Gray Matter Structures for Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Mohammadi S; Ghaderi S; Fatehi F
    Brain Behav; 2024 Oct; 14(10):e70093. PubMed ID: 39415615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
    Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
    Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative susceptibility mapping for iron monitoring of multiple subcortical nuclei in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Mohammadi S; Ghaderi S; Sayehmiri F; Fathi M
    Front Endocrinol (Lausanne); 2024; 15():1331831. PubMed ID: 38510699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five year iron changes in relapsing-remitting multiple sclerosis deep gray matter compared to healthy controls.
    Elkady AM; Cobzas D; Sun H; Seres P; Blevins G; Wilman AH
    Mult Scler Relat Disord; 2019 Aug; 33():107-115. PubMed ID: 31181540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
    Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
    Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
    Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
    J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis.
    Voon CC; Wiltgen T; Wiestler B; Schlaeger S; Mühlau M
    Neuroimage Clin; 2024; 42():103598. PubMed ID: 38582068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron deposition and atrophy in cerebral grey matter and their possible association with serum iron in relapsing-remitting multiple sclerosis.
    Al-Radaideh A; El-Haj N; Hijjawi N
    Clin Imaging; 2021 Jan; 69():238-242. PubMed ID: 32977196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron quantification in basal ganglia: quantitative susceptibility mapping as a potential biomarker for Alzheimer's disease - a systematic review and meta-analysis.
    Ghaderi S; Mohammadi S; Nezhad NJ; Karami S; Sayehmiri F
    Front Neurosci; 2024; 18():1338891. PubMed ID: 38469572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of deep gray matter atrophy on information processing speed in early relapsing-remitting multiple sclerosis.
    Naghavi S; Ashtari F; Adibi I; Shaygannejad V; Ramezani N; Pourmohammadi A; Davanian F; Karimi Z; Khaligh-Razavi SM; Sanayei M
    Mult Scler Relat Disord; 2023 Mar; 71():104560. PubMed ID: 36806043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive iron accumulation across multiple sclerosis phenotypes revealed by sparse classification of deep gray matter.
    Elkady AM; Cobzas D; Sun H; Blevins G; Wilman AH
    J Magn Reson Imaging; 2017 Nov; 46(5):1464-1473. PubMed ID: 28301067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis.
    Rubin M; Pagani E; Preziosa P; Meani A; Storelli L; Margoni M; Filippi M; Rocca MA
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200271. PubMed ID: 38896808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
    Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
    Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Increase of Mean Susceptibility and Mean Kurtosis in the Substantia Nigra as an MRI Neuroimaging Biomarker for Early-Stage Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Mohammadi S; Ghaderi S; Mohammadi H; Fatehi F
    J Magn Reson Imaging; 2024 Aug; ():. PubMed ID: 39210501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.
    Schweser F; Raffaini Duarte Martins AL; Hagemeier J; Lin F; Hanspach J; Weinstock-Guttman B; Hametner S; Bergsland N; Dwyer MG; Zivadinov R
    Neuroimage; 2018 Feb; 167():438-452. PubMed ID: 29097315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosis.
    Callen AM; Zurawski J; Chu R; Tie Y; Tauhid S; Quattrucci M; Healy BC; Bakshi R
    J Neurol; 2024 Oct; 271(10):6935-6943. PubMed ID: 39240345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis.
    Pudlac A; Burgetova A; Dusek P; Nytrova P; Vaneckova M; Horakova D; Krasensky J; Lambert L
    Biomed Res Int; 2020; 2020():6492786. PubMed ID: 32509866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
    Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
    J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
    Bergsland N; Zivadinov R; Dwyer MG; Weinstock-Guttman B; Benedict RH
    Mult Scler; 2016 Sep; 22(10):1327-36. PubMed ID: 26541795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.